LabCorp

“agreed to buy the lab testing business of BioReference Health from OPKO Health for $722m in cash upfront and $150m of potential earnouts.”

“The lab industry in general is a very low margin industry and it's built on efficiency... if you're asking them to 10x capacity that's literally the opposite of what they're built for... You look at the big labs, the Quest and LabCorps and they are ultra efficient machines”